Skip to content

Nicola M. Dempster

University of California, San Diego

3 papers in the library · 139 citations · publishing 2013-2020

Papers

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD)

Drug Testing and Analysis May 13, 2019 Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal et al. 72 citations

1-Butanoyl-LSD (1B-LSD), a new analog of lysergic acid diethylamide (LSD), was fully characterized using multiple analytical techniques including NMR, mass spectrometry, and infrared spectroscopy, allowing clear differentiation from a similar compound, 1P-ETH-LAD. In behavioral tests with C57BL/6J mice, 1B-LSD produced a dose-dependent increase in head-twitch response, a marker of serotonergic hallucinogen activity, though with only about 14% of LSD's potency (ED50 = 976.7 nmol/kg vs. 132.8 nmol/kg for LSD). This suggests 1B-LSD has LSD-like behavioral effects and may act as a pro-drug for LSD, but further research is needed to confirm psychoactive effects in humans.

Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD)

Drug Testing and Analysis March 16, 2020 Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal et al. 38 citations

1-Cylopropanoyl-LSD (1CP-LSD), a new lysergamide-based designer drug, was analyzed using multiple chemical and spectroscopic methods. Incubation with human serum converted 1CP-LSD into LSD, suggesting it may act as a prodrug for LSD in the body. In mice, 1CP-LSD induced a head-twitch response (HTR) with an ED50 of 430.0 nmol/kg, comparable to 1P-LSD (ED50 = 349.6 nmol/kg), indicating an LSD-like behavioral profile. The study includes analysis of blotters and pellets, and detected artificially induced degradation products during GC-MS analysis. Clinical studies are needed to determine its potency and effects in humans.

Determination of N,N-dimethyltryptamine in beverages consumed in religious practices by headspace solid-phase microextraction followed by gas chromatography ion trap mass spectrometry

Talanta February 1, 2013 Alain Gaujac, Nicola M. Dempster, Sandro Navickiene et al. 29 citations

A method using solid-phase microextraction (SPME) combined with gas chromatography ion trap mass spectrometry (GC-IT-MS) reliably detects and measures N,N-dimethyltryptamine (DMT) in ayahuasca and vinho da jurema, plant-based beverages used in South American religious ceremonies. The technique, optimized with a PDMS/DVB fiber at 60°C for 70 minutes, achieves good precision (relative standard deviation below 8.6%), accuracy (71–109%), and a detection limit of 0.78 mg/L. Analysis of twelve real samples from Brazilian religious groups found DMT concentrations ranging from 0.10 to 1.81 g/L. The method minimizes sample handling and is robust for quantifying DMT in these increasingly globally available beverages.